InvestSMART

Dimerix Limited (ASX: DXB) - Announcements

Current share price for DXB : $0.210 0.005 (2.33%)+

ASX company news and announcements for Dimerix Limited (DXB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Dimerix Limited (DXB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Dimerix Limited (DXB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Dimerix Limited (DXB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$126 Change of Director's Interest Notices - JW, HA, SP and NW 5 Oct 2021 11:41AM $0.275 $0.210 fallen by 23.64%
$126 Notification regarding unquoted securities - DXB 5 Oct 2021 11:19AM $0.278 $0.210 fallen by 24.32%
$126 Notification regarding unquoted securities - DXB 5 Oct 2021 11:15AM $0.278 $0.210 fallen by 24.32%
$126 Notification regarding unquoted securities - DXB 5 Oct 2021 11:10AM $0.278 $0.210 fallen by 24.32%
$126 Notification regarding unquoted securities - DXB 5 Oct 2021 11:04AM $0.278 $0.210 fallen by 24.32%
$126 Application for quotation of securities - DXB 5 Oct 2021 11:00AM $0.275 $0.210 fallen by 23.64%
$126 Application for quotation of securities - DXB 5 Oct 2021 10:57AM $0.275 $0.210 fallen by 23.64%
$126 Dimerix Closes SPP Oversubscribed 1 Oct 2021 9:17AM $0.300 $0.210 fallen by 30%
$126 Results of Meeting 27 Sep 2021 3:14PM $0.330 $0.210 fallen by 36.36%
$126 AGM Presentation 27 Sep 2021 2:06PM $0.345 $0.210 fallen by 39.13%
$126 CEO's Address to Shareholders 27 Sep 2021 2:06PM $0.345 $0.210 fallen by 39.13%
$126 Virtual Meeting Voting and Registration Guide 27 Sep 2021 8:49AM $0.310 $0.210 fallen by 32.26%
$126 DMX-200 CLARITY COVID-19 Study Approval in India 24 Sep 2021 9:55AM $0.280 $0.210 fallen by 25%
$126 Change of Director's Interest Notices - JW, HA and SP 15 Sep 2021 3:16PM $0.300 $0.210 fallen by 30%
$126 Change in substantial holding 3 Sep 2021 12:48PM $0.348 $0.210 fallen by 39.57%
$126 Phase 3 Study in FSGS Kidney Patients Commences 25 Aug 2021 8:42AM $0.300 $0.210 fallen by 30%
$126 Notice of Annual General Meeting/Proxy Form 24 Aug 2021 9:20AM $0.340 $0.210 fallen by 38.24%
$126 Annual General Meeting - Notice and Letter to Shareholders 24 Aug 2021 9:13AM $0.340 $0.210 fallen by 38.24%
$126 SPP and Options Prospectus 24 Aug 2021 9:06AM $0.340 $0.210 fallen by 38.24%
$126 Secondary Trading Notice Pursuant to Section 708A(5)(e) 24 Aug 2021 8:26AM $0.340 $0.210 fallen by 38.24%
$126 Application for quotation of securities - DXB 24 Aug 2021 8:22AM $0.340 $0.210 fallen by 38.24%
$126 Application for quotation of securities - DXB 24 Aug 2021 8:18AM $0.340 $0.210 fallen by 38.24%
$126 Response to ASX Query 19 Aug 2021 11:26AM $0.300 $0.210 fallen by 30%
$126 Secondary Trading Notice Pursuant to Section 708A(5)(e) 18 Aug 2021 2:14PM $0.300 $0.210 fallen by 30%
$126 Application for quotation of securities - DXB 18 Aug 2021 2:02PM $0.305 $0.210 fallen by 31.15%

401 - 425 of 745 results

Page 17 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.